Infection Control Market 2026-2035

Infection Control Market Size, Share & Trends Analysis Report By Equipment (Disinfectors and Sterilization Equipment), By End-User (Hospitals and Clinics, Pharmaceutical Companies, Medical Device Companies, and Others), By Services (ETO Sterilization Services, Gamma Sterilization Services, E-Beam Sterilization Services, and Others) Forecast Period, (2026-2035)

Industry Overview

Infection control market was valued at $8,100.0 million in 2025 and is projected to reach $14,642.2 million by 2035, growing at a CAGR of 6.2% during the forecast period (2026-2035). The global infection control market is evolving steadily as healthcare systems worldwide intensify their focus on patient safety, hospital-acquired infection (HAI) reduction, and compliance with stringent hygiene standards. Market growth is being driven by the increasing adoption of advanced sterilization and disinfection technologies, automated reprocessing equipment, and single-use medical consumables that enhance operational efficiency and consistency in infection prevention practices. Demand is further supported by the rising burden of chronic diseases, growing surgical volumes, and the expansion of healthcare infrastructure across emerging economies. As regulatory bodies reinforce infection prevention protocols and accreditation requirements, infection control solutions are becoming critical in minimizing cross-contamination risks, improving clinical outcomes, and ensuring continuity of care across healthcare settings.

Market Dynamics

Rising Emphasis on Healthcare-Associated Infection (HAI) Prevention and Patient Safety

Healthcare providers and regulatory authorities are increasingly prioritizing infection prevention as a core component of quality care delivery. Hospitals, clinics, and long-term care facilities are strengthening their infection control protocols to reduce HAIs, improve patient outcomes, and limit financial penalties associated with non-compliance. This focus is driving sustained demand for sterilization equipment, disinfectants, personal protective equipment (PPE), and environmental hygiene solutions. As healthcare systems adopt standardized and evidence-based infection prevention frameworks, investment in reliable and compliant infection control products continues to accelerate. This growing emphasis on patient safety is becoming a fundamental driver shaping the global infection control market.

Expanding Adoption of Advanced Technologies and Automated Infection Control Solutions

Automation and technological innovation are increasingly being integrated into infection control workflows to improve consistency, efficiency, and traceability. Advanced sterilization systems, automated endoscope preprocessors, UV disinfection technologies, and digital monitoring tools are gaining traction across healthcare settings. These solutions help reduce human error, optimize resource utilization, and support compliance with evolving regulatory standards. Manufacturers are focusing on developing scalable and user-friendly systems that can be seamlessly incorporated into existing healthcare infrastructure. As facilities seek to enhance operational efficiency while maintaining high hygiene standards, the adoption of technologically advanced infection control solutions is emerging as a key growth catalyst for the global market.

Market Segmentation

• Based on the equipment, the market is segmented into disinfectors and sterilization equipment.
• Based on the end-user, the market is segmented into hospitals and clinics, pharmaceutical companies, medical device companies, and others.
• Based on the services, the market is segmented into ETO sterilization services, gamma sterilization services, e-beam sterilization services, and others.

Sterilization Equipment Segment to Account for the Largest Market Share

The sterilization equipment segment is expected to hold a dominant position in the global infection control market, driven by its critical role in eliminating pathogens and preventing cross-contamination across healthcare environments. Hospitals, clinics, and life science facilities increasingly depend on advanced sterilization systems to ensure compliance with stringent hygiene and safety standards. Rising surgical volumes, greater use of reusable medical instruments, and the growing complexity of medical procedures are reinforcing demand for reliable sterilization technologies. Continuous advancements in low-temperature, automated, and environmentally efficient sterilization systems are further enhancing adoption. As infection prevention remains a top clinical priority, sterilization equipment continues to anchor this segment’s leading market share.

Hospitals and Clinics: The Largest End-User Segment Driving Demand

Hospitals and clinics represent the significant end-user segment in the infection control market, supported by their high patient throughput and elevated risk of healthcare-associated infections. These facilities require comprehensive infection prevention solutions spanning disinfection, sterilization, and protective consumables to maintain safe care environments. Increasing regulatory scrutiny, accreditation requirements, and public awareness around patient safety are prompting healthcare providers to strengthen infection control investments. Additionally, the expansion of hospital infrastructure and outpatient services in both developed and emerging markets is amplifying product adoption. Together, these factors position hospitals and clinics as a central force shaping overall market growth.

Regional Outlook

The global infection control market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Strengthening Infection Prevention Infrastructure Across Europe

Europe is witnessing consistent growth in the infection control market as healthcare systems, pharmaceutical manufacturers, and research institutions intensify their focus on standardized hygiene practices and patient safety. Ongoing investments in hospital modernization, medical device manufacturing, and public health infrastructure are supporting wider adoption of advanced sterilization and disinfection technologies. Regional initiatives aimed at reducing healthcare-associated infections are encouraging the use of automated, traceable, and compliance-ready infection control solutions. Manufacturers are also aligning product designs with Europe’s stringent regulatory and quality standards, improving market penetration. With sustained emphasis on safety, sustainability, and regulatory compliance, Europe continues to build a robust foundation for infection control market expansion.

North America Dominates the Infection Control Market with the Largest Share

North America holds a leading position in the global infection control market, driven by its advanced healthcare infrastructure and strong focus on infection prevention protocols. Hospitals and healthcare facilities across the region consistently invest in high-performance sterilization equipment, disinfectants, and monitoring solutions to comply with strict regulatory and accreditation requirements. The presence of major market players, combined with continuous technological innovation, further supports market leadership. High awareness of healthcare-associated infection risks and substantial healthcare spending enable rapid adoption of advanced infection control solutions. Collectively, these factors reinforce North America’s dominant share and sustained growth momentum in the global infection control market.

Market Players Outlook

The major companies operating in the global infection control market include 3M Company, Becton, Dickinson and Company, Ecolab Inc., Getinge AB, STERIS plc, among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

• In June 2025, STERIS plc introduced an advanced low-temperature sterilization system designed for complex and heat-sensitive medical devices. The new platform integrates automated cycle monitoring and digital traceability features to support compliance with evolving hospital infection prevention standards and improve reprocessing efficiency.
• In April 2025, 3M expanded its infection prevention portfolio with the launch of next-generation surface disinfectant solutions featuring enhanced efficacy against a broad spectrum of pathogens. The products are formulated to reduce contact time while supporting environmental sustainability goals, reinforcing 3M’s focus on safer and more efficient healthcare hygiene practices.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global infection control market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.

Show more